| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-11 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-08 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-06 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-06 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |